CBRA Publications

Cost-effectiveness and budget effect analysis of a population-based skin cancer screening
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Annemans L, Brochez L.
JAMA Dermatol. 2017; 153:147-153
Belgium ⁃ Cost-effectiveness

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Brochez L, Annemans L.
Prev Med. 2017; 93:177-182
Belgium ⁃ Burden ⁃ Cost-effectiveness

Cost-effectiveness analysis in melanoma detection: a transition model applied to dermoscopy
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Sacré L, Baurain J-F, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 67:38-45
Belgium ⁃ Cost-effectiveness

Melanoma burden by melanoma stage: assessment through a disease transition model
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Francart J, Calay F, Haagsma JA, Baurain J, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 53:33-41
Belgium ⁃ Burden

Health related quality of life in melanoma patients expressed as utilities and disability weights
Tromme I, Devleesschauwer B, Beutels P, Richez P, Leroy A, Baurain J-F, Cornelis F, Bertrand C, Legrand N, Degueldre J, Thomas L, Legrand C, Lambert J, Haagsma J, Speybroeck N.
Br J Dermatol. 2014; 171:1443-1450
Belgium ⁃ Disability weights

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a Belgian study of patients with a single or a small number of atypical nevi
Tromme I, Devleesschauwer B, Beutels P, Richez P, Praet N, Sacré L, Marot L, Van Eeckhout P, Theate I, Baurain JF, Lambert J, Legrand C, Thomas L, Speybroeck N.
PLOS ONE. 2014; 9:e109339
Belgium ⁃ Cost-effectiveness